Has Jeffrey Turner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,376 in general payments to Jeffrey Turner, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Turner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Turner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Turner, MD

Nephrology · New Haven, CTNPI 1881915601

Payments from drug & device makers

What this record shows

Bayer accounts for 79.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $1,092 and has fallen 94.2% since, to $63 in 2025.

$1,376in general payments, 2019–2025

Across 14 payments — averaging $98.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bayer$1K
Bard Peripheral Vascular, Inc.$135
Ablative Solutions, Inc.$85
Vantive US Healthcare LLC$63

$1,304,597in research payments, 2019–2025

Across 383 payments — averaging $3406.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$312K
Bayer$255K
Vertex$229K
Boehringer Ingelheim Pharma GmbH & Co.kg$203K
Boehringer Ingelheim International GmbH$167K
AstraZeneca$88K
plus $50K from 2 others

What the payments were for

Travel & lodging$80058%
Food & beverage$57642%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bayer	9	$1,092
Bard Peripheral Vascular, Inc.	2	$135
Ablative Solutions, Inc.	1	$85
Vantive US Healthcare LLC	2	$63

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Kerendia$638

How this compares

$1,376 in reported general payments places this provider in the 65th percentile of 144 nephrology providers in Connecticut.

See all nephrology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$69,713

Medicare patients

186

Services billed

533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	14	$22,092
LokelmaSodium Zirconium Cyclosilicate	16	$14,668
Sevelamer Carbonate	28	$8,069
Calcitriol	33	$711
Torsemide	16	$494
Bumetanide	13	$479
Oxycodone Hcl	16	$452
Lidocaine-PrilocaineLidocaine/Prilocaine	11	$363
Carvedilol	18	$269
Doxazosin Mesylate	13	$266
Amlodipine Besylate	47	$263
Chlorthalidone	12	$251
Losartan Potassium	31	$244
Pantoprazole Sodium	13	$161
Lactulose	12	$117

Paid to pharmacies, not to this prescriber.

Other nephrology in New Haven

Robert AlpernNew Haven$4.9M
Richard FormicaNew Haven$198K
Stefan SomloNew Haven$111K
Fredric FinkelsteinNew Haven$70K
Justin BelcherNew Haven$59K
Ladan GolestanehNew Haven$54K
Aldo PeixotoNew Haven$17K
Ali Abu-AlfaNew Haven$16K
Lloyd CantleyNew Haven$14K
Sue ChangNew Haven$9K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →